Cargando…
Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3)
Cromolyn is a known mast cell stabilizer and is approved for treatment of asthma and for other allergic indications. Cromolyn, in a new redesigned dry powder formulation, is being tested in a pivotal clinical trial in combination with low dose ibuprofen to treat early Alzheimer’s Disease (AD) subjec...
Autores principales: | Wang, Yi-Jun, Monteagudo, Alina, Downey, Matthew A., Ashton-Rickardt, Philip G., Elmaleh, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044132/ https://www.ncbi.nlm.nih.gov/pubmed/33850164 http://dx.doi.org/10.1038/s41598-021-85702-8 |
Ejemplares similares
-
Cromolyn platform suppresses fibrosis and inflammation, promotes microglial phagocytosis and neurite outgrowth
por: Wang, Yi-Jun, et al.
Publicado: (2021) -
Pharmacokinetics of Cromolyn and Ibuprofen in Healthy Elderly Volunteers
por: Brazier, David, et al.
Publicado: (2017) -
Cromolyn Reduces Levels of the Alzheimer’s Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis
por: Zhang, Can, et al.
Publicado: (2018) -
Anti-inflammatory cytokine stimulation of HMC3 cells: Proteome dataset
por: Ahuja, Shreya, et al.
Publicado: (2023) -
Effects of cromolyn sodium on isolated rat's trachea
por: Lin, Yuan-Yung, et al.
Publicado: (2011)